#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA661070	F	Dose estimated to produce 25 mm Hg fall in mean systemic blood pressure of anesthetized cat at 10 min after administration	Felis catus	45		organism-based format	Scientific Literature
2.	ALA740243	T	Acute toxicity was measured as LD50 in mice after ip administration.	Mus musculus	3		organism-based format	Scientific Literature
3.	ALA771214	F	Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure	Rattus norvegicus	1		organism-based format	Scientific Literature
4.	ALA776113	F	Antihypertensive activity was measured as ED20 which is the dose lowered the normal arterial pressure in conscious SH rats by 20% after po administration.	Rattus norvegicus	3		organism-based format	Scientific Literature
5.	ALA781586	F	Hypotensive activity was measured as ED20 which is the dose lowered the normal arterial pressure in anesthetized rats by 20% after ip administration.	Rattus norvegicus	2		organism-based format	Scientific Literature
6.	ALA781588	F	Hypotensive activity was measured as ED20 which is the dose lowered the normal arterial pressure in anesthetized rats by 20% after iv administration.	Rattus norvegicus	5		organism-based format	Scientific Literature
7.	ALA780852	F	Compound was tested for antihypertensive activity in normotensive rats and the dose that lowered by 25 mmHg of the blood pressure was determined	Rattus norvegicus	1		organism-based format	Scientific Literature
8.	ALA780859	F	Dose that lowers blood pressure by 25 mm Hg was determined in spontaneous hypertensive rats (SHR)	Rattus norvegicus	6		organism-based format	Scientific Literature
9.	ALA778158	F	Difference in systolic blood pressure of SH rats observed prior to the first application and 2 hr after the fifth application at the oral dose of 5 mg/kg was expressed as Delta BP	Rattus norvegicus	10		organism-based format	Scientific Literature
10.	ALA784532	F	divya_inp96 Antihypertensive activity in hypertensive rats, after peroral administration that lowered the blood pressure by 50 mmHg	Rattus norvegicus	1		organism-based format	Scientific Literature
11.	ALA790536	F	Relative potency of compound was measured in anesthetized rats after iv administration.	Rattus norvegicus	5		organism-based format	Scientific Literature
12.	ALA790538	F	Relative potency of compound was measured in conscious SH rats after po administration.	Rattus norvegicus	4		organism-based format	Scientific Literature
13.	ALA791675	F	Antihypertensive action versus dihydralazine	Rattus norvegicus	6		organism-based format	Scientific Literature
14.	ALA790289	F	Variation in heart rate when 25 mg/kg administered orally in rats	Rattus norvegicus	8		organism-based format	Scientific Literature
15.	ALA840551	F	In vitro inhibition of ADP-induced human platelet aggregation	Homo sapiens	41		organism-based format	Scientific Literature
16.	ALA840552	F	In vitro inhibition of collagen-induced human platelet aggregation.	Homo sapiens	43		organism-based format	Scientific Literature
17.	ALA841426	F	Relative activity (compared to acetylsalicylic acid) for in vitro inhibition of collagen-induced human platelet aggregation	Homo sapiens	43		organism-based format	Scientific Literature
18.	ALA844698	F	relative activity with respect to the dihydralazine was determined		1		assay format	Scientific Literature
19.	ALA847714	F	In vitro hypotensive activity in anesthetized rats after intraperitoneal administration.	Rattus norvegicus	41		organism-based format	Scientific Literature
20.	ALA849664	F	Activity relative to dihydralazine for in vitro hypotensive activity in anesthetized rats	Rattus norvegicus	41		organism-based format	Scientific Literature